Targeting Beta Amyloid: A Clinical Review of Immunotherapeutic Approaches in Alzheimer's Disease
International Journal of Alzheimer's Disease · 2012 · 2012 · 1-14
DOI: 10.1155/2012/628070 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Alzheimer's Disease, 2012. Verfasst von Kasia Lobello und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, Pfizer Inc., Collegeville, PA 19426, USA. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Themen: Demenz
Abstract (Originalsprache)
As the societal and economic burdens of Alzheimer's disease (AD) continue to mount, so does the need for therapies that slow the progression of the illness. Beta amyloid has long been recognized as the pathologic hallmark of AD, and the past decade has seen significant progress in the development of various immunotherapeutic approaches targeting beta amyloid. This paper reviews active and passive approaches aimed at beta amyloid, with a focus on clinical trial data.
Autor:innen und Institutionen
- Department of Clinical Sciences, Pfizer Inc., Collegeville, PA 19426, USA.
Zitieren
APA
Lobello, K., Ryan, J. M., Liu, E., Rippon, G., & Black, R. (2012). Targeting Beta Amyloid: A Clinical Review of Immunotherapeutic Approaches in Alzheimer's Disease. International Journal of Alzheimer's Disease, 2012, 1-14. https://doi.org/10.1155/2012/628070
Vancouver
Lobello K, Ryan JM, Liu E, Rippon G, Black R. Targeting Beta Amyloid: A Clinical Review of Immunotherapeutic Approaches in Alzheimer's Disease. International Journal of Alzheimer's Disease. 2012;2012:1-14. doi:10.1155/2012/628070
BibTeX
@article{Lobello2012,
author = {Lobello, Kasia and Ryan, J Michael and Liu, Enchi and Rippon, Gregory and Black, Ronald},
title = {Targeting Beta Amyloid: A Clinical Review of Immunotherapeutic Approaches in Alzheimer's Disease},
journal = {International Journal of Alzheimer's Disease},
year = {2012},
volume = {2012},
pages = {1--14},
doi = {10.1155/2012/628070}
}
EUVIMED